William Blair & Company
ANRO icon

William Blair & Company’s Alto Neuroscience ANRO Stock Holding History

William Blair & Company’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$154K – 1887
2024
Q1 		$154K Buy
+10,000
New +$157K ﹤0.01% 1450

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

William Blair & Company's ANRO Position: Q2 2024 in Review

William Blair & Company sold out of Alto Neuroscience (ANRO) in Q2 2024, closing a stake of 10,000 shares — an estimated $154K sold.

William Blair & Company first reported a position in ANRO in Q1 2024 and held it in 1 quarter. The position peaked at $154K in Q1 2024. 58 funds tracked by Wall St. Rank hold ANRO as of Q2 2024.

  • William Blair & Company reported no remaining Alto Neuroscience position as of Q2 2024 after selling out during the quarter.
  • William Blair & Company sold 10,000 Alto Neuroscience shares in Q2 2024, an estimated $154K.
  • William Blair & Company first reported a position in Alto Neuroscience in Q1 2024 and held it in 1 quarter.
  • William Blair & Company's Alto Neuroscience position peaked at $154K in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2024.

Based on William Blair & Company's 13F filing for Q2 2024, filed 12 Aug 2024.